Desjardins Global Asset Management Inc. United Therapeutics Corp Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 7,165 shares of UTHR stock, worth $2.55 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
7,165
Previous 7,311
2.0%
Holding current value
$2.55 Million
Previous $1.65 Million
4.6%
% of portfolio
0.17%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
618Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.95 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.57 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.17 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$816 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...